APOE and Alzheimer disease: Of interest, Study 3 [16] demonstrated increased expression of OXPHOS subunits in young asymptomatic APOE4 carriers, and Study 15 [2] observed increased expression in individuals with AD pathology but normal cognition (AD-resilient) compared to elderly non-demented individuals.